Ezetimibe【C】

Cardiovascular – Renal Drugs : Hyperlipidemia
OEZET1 “Ezetrol tablet” 10 mg/cap

適應症:原發性高膽固醇血症、同型接合子家族性高膽固醇血症、同型接合子性麥脂醇血症(植物脂醇血症)。

Usual dose:

Familial hypercholesterolemia – homozygous:

Adult & Pediatric: with atorvastatin or simvastatin, 10 mg qd.

Mixed hyperlipidemia:

Adult: in combination with fenofibrate, 10 mg qd.

Primary hypercholesterolemia:

Adult: alone or in combination with an HMG-CoA reductase inhibitor (statin), 10 mg qd.

Sitosterolemia, Homozygous familial:

Adult & Pediatric: 10 mg qd.

Contraindication:

Active liver disease or persistently elevated liver enzymes (when coadministered with a statin).

Adverse effect:

Common: diarrhea, arthralgia, myalgia, nasopharyngitis, sinusitis, upper respiratory infection.

Serious: increased liver function test, anaphylaxis, disorder of muscle, rhabdomyolysis.

健保使用規範:(94/6/1)

  1. 原發性高膽固醇血症、同型接合子家族性高膽固醇血症、同型接合子性麥脂醇血症(植物脂醇血症)患者並符合下列條件之一者:

(1)符合全民健康保險降血脂藥物給付規定表且對Statins類藥品發生無法耐受藥物不良反應(如Severe myalgia、Myositis)者。

(2)符合全民健康保險降血脂藥物給付規定表經使用Statins類藥品單一治療3個月未達治療目標者,得合併使用本案藥品與Statins類藥品。。

2.見全民健康保險降血脂藥物給付規定表。(86/1/1、87/4/1、87/7/1、91/9/1、93/9/1、97/7/1、102/8/1)

Related Entries

(Visited 631 times, 1 visits today)